Artificial Intelligence in Drug Discovery
En podkast av Simon Smith
Kategorier:
12 Episoder
-
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
Publisert: 7.8.2018 -
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
Publisert: 7.8.2018 -
Regina Barzilay, AI Small Molecule Discovery and Synthesis
Publisert: 30.7.2018 -
Tim Guilliams and David Brown, Healx, AI for Rare Diseases
Publisert: 26.7.2018 -
John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology
Publisert: 18.7.2018 -
Kristen Fortney, CEO of BioAge Labs, on AI Aging Research
Publisert: 10.7.2018 -
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
Publisert: 28.6.2018 -
Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology
Publisert: 20.6.2018 -
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
Publisert: 11.6.2018 -
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
Publisert: 29.5.2018 -
Mauro Cozzi, Researchably, AI for Better Biomedical Search
Publisert: 22.5.2018 -
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"
Publisert: 14.5.2018
1 / 1
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!